Clinical Trial Update: Sodium-Lactate and Traumatic Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating sodium lactate for severe traumatic brain injury with intracranial hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hypertension
• Traumatic Brain Injury

Drugs mentioned

• Sodium lactate (sodium lactate)

Snippet

Sponsor: Institut d'Anesthesiologie des Alpes Maritimes | Conditions: Severe Trauma Brain Injury, Intracranial Hypertension | Phase 2, Phase 3 | Status: TERMINATED